Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial
-
Published:2024-04-07
Issue:7
Volume:16
Page:1083
-
ISSN:2072-6643
-
Container-title:Nutrients
-
language:en
-
Short-container-title:Nutrients
Author:
Redondo-Cuevas Lucia1ORCID, Belloch Lucia1, Martín-Carbonell Vanesa12, Nicolás Angela1, Alexandra Iulia2, Sanchis Laura12ORCID, Ynfante Marina1, Colmenares Michel1, Mora María1, Liebana Ana Reyes1, Antequera Beatriz1, Grau Francisco1, Molés José Ramón12, Cuesta Rubén2, Díaz Samuel1, Sancho Noelia1, Tomás Héctor1, Gonzalvo José2, Jaén Mercedes12, Sánchez Eva12, Garayoa Ana2, Moreno Nadia1, Gallén Ana1, Cortés-Castell Ernesto3ORCID, Cortés-Rizo Xavier12ORCID
Affiliation:
1. Valencian Digestive Institute (IVADI), 46021 Valencia, Spain 2. Digestive Section, Hospital de Sagunto Internal Medicine Service, 46520 Valencia, Spain 3. Department of Pharmacology, Pediatrics and Organic Chemistry, Miguel Hernández University of Elche, 03550 Elche, Spain
Abstract
Small intestinal bacterial overgrowth (SIBO) arises from dysbiosis in the small intestine, manifesting with abdominal symptoms. This study aims to assess the efficacy of combined antibiotic therapy, herbal supplements, probiotics, and dietary modifications in SIBO management. A total of 179 SIBO-diagnosed patients underwent clinical evaluation and breath testing. Patients were categorized into hydrogen (H2-SIBO) and methane (CH4-SIBO) groups. The control group received standard antibiotic therapy and a low-FODMAP diet, while the intervention group received additional herbal antibiotics, probiotics, and prebiotics. After treatment, both groups exhibited reduced gas levels, particularly in CH4-SIBO. Clinical remission rates were higher in the intervention group, especially in CH4-SIBO cases. Logistic regression analysis showed gas concentrations at diagnosis as significant predictors of treatment success. In conclusion, adjunctive herbal supplements and probiotics did not significantly impact gas levels, but showed potential for clinical improvement, especially in CH4-SIBO.
Reference44 articles.
1. Mechanisms and consequences of intestinal dysbiosis;Weiss;Cell Mol. Life Sci.,2017 2. Altered gut microbiota in patients with small intestinal bacterial overgrowth;Bamba;J. Gastroenterol. Hepatol.,2022 3. Li, J., Zhang, R., Ma, J., Tang, S., Li, Y., Li, Y., and Wan, J. (2021). Mucosa-Associated Microbial Profile Is Altered in Small Intestinal Bacterial Overgrowth. Front. Microbiol., 12. 4. Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management;Bushyhead;Gastroenterology,2022 5. Oana, K., Shimizu, K., Takada, T., Makino, H., Yamazaki, M., Katto, M., Ando, M., Kurakawa, T., and Oishi, K. (2023). Manipulating the growth environment through co-culture to enhance stress tolerance and viability of probiotic strains in the gastrointestinal tract. Appl. Environ. Microbiol., 89.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|